Is There a Place for Chimeric Antigen Receptor–T Cells in the Treatment of Chronic Autoimmune Rheumatic Diseases?
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Is There a Place for Chimeric Antigen Receptor–T Cells in the Treatment of Chronic Autoimmune Rheumatic Diseases?
Authors
Keywords
-
Journal
Arthritis & Rheumatology
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-05-27
DOI
10.1002/art.41812
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-CD20–mediated B-cell depletion in autoimmune diseases: successes, failures and future perspectives
- (2020) Etienne Crickx et al. KIDNEY INTERNATIONAL
- Single residue in CD28-costimulated CAR-T cells limits long-term persistence and antitumor durability
- (2020) Sonia Guedan et al. JOURNAL OF CLINICAL INVESTIGATION
- Regulatory T cell therapy: Current and future design perspectives
- (2020) Jyoti Rana et al. CELLULAR IMMUNOLOGY
- CD19-targeted CAR regulatory T cells suppress B cell pathology without GvHD
- (2020) Yuki Imura et al. JCI Insight
- In vitro elimination of autoreactive B cells from rheumatoid arthritis patients by universal chimeric antigen receptor T cells
- (2020) Bo Zhang et al. ANNALS OF THE RHEUMATIC DISEASES
- Antigen-specific B cell depletion for precision therapy of mucosal pemphigus vulgaris
- (2020) Jinmin Lee et al. JOURNAL OF CLINICAL INVESTIGATION
- Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus
- (2019) Rita Kansal et al. Science Translational Medicine
- Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study
- (2019) Muriel Elhai et al. ANNALS OF THE RHEUMATIC DISEASES
- Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease
- (2019) Oliver Distler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes
- (2019) Michel Tenspolde et al. JOURNAL OF AUTOIMMUNITY
- Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Multiply Relapsed or Refractory Adult Large B-Cell Lymphoma
- (2019) John K. Lin et al. JOURNAL OF CLINICAL ONCOLOGY
- The Role of Monocytes and Macrophages in Autoimmune Diseases: A Comprehensive Review
- (2019) Wen-Tao Ma et al. Frontiers in Immunology
- Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial
- (2019) Jing He et al. ANNALS OF THE RHEUMATIC DISEASES
- Targeting cardiac fibrosis with engineered T cells
- (2019) Haig Aghajanian et al. NATURE
- Low-Dose IL-2 Therapy in Transplantation, Autoimmunity, and Inflammatory Diseases
- (2019) Maryam Tahvildari et al. JOURNAL OF IMMUNOLOGY
- Immunization to rituximab is more frequent in systemic autoimmune diseases than in rheumatoid arthritis: ofatumumab as alternative therapy
- (2019) Alice Combier et al. RHEUMATOLOGY
- Engineering strategies to overcome the current roadblocks in CAR T cell therapy
- (2019) Sarwish Rafiq et al. Nature Reviews Clinical Oncology
- Efficacy and safety of rituximab in systemic sclerosis: French retrospective study and literature review
- (2018) Mathilde Thiebaut et al. AUTOIMMUNITY REVIEWS
- Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
- (2018) Jae H. Park et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chimeric antigen receptor (CAR) T cells targeting a pathogenic MHC class II:peptide complex modulate the progression of autoimmune diabetes
- (2018) Li Zhang et al. JOURNAL OF AUTOIMMUNITY
- Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial
- (2018) Michelle Rosenzwajg et al. ANNALS OF THE RHEUMATIC DISEASES
- New therapeutic strategies in systemic lupus erythematosus management
- (2018) Mariele Gatto et al. Nature Reviews Rheumatology
- Adoptive Regulatory T Cell Therapy in a Patient with Systemic Lupus Erythematosus
- (2018) Maria Dall'Era et al. Arthritis & Rheumatology
- Regulatory T Cells in Systemic Sclerosis
- (2018) Camelia Frantz et al. Frontiers in Immunology
- Function of Novel Anti-CD19 Chimeric Antigen Receptors with Human Variable Regions Is Affected by Hinge and Transmembrane Domains
- (2017) Leah Alabanza et al. MOLECULAR THERAPY
- Therapeutic T cell engineering
- (2017) Michel Sadelain et al. NATURE
- Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
- (2017) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- A multicenter, open-label, comparative study of B-cell depletion therapy with Rituximab for systemic sclerosis-associated interstitial lung disease
- (2017) Dimitrios Daoussis et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Inducible Activation of MyD88 and CD40 in CAR T Cells Results in Controllable and Potent Antitumor Activity in Preclinical Solid Tumor Models
- (2017) Melinda Mata et al. Cancer Discovery
- Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy
- (2016) V. G. Bhoj et al. BLOOD
- Progress in understanding the diagnostic and pathogenic role of autoantibodies associated with systemic sclerosis
- (2016) May Y. Choi et al. CURRENT OPINION IN RHEUMATOLOGY
- Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells
- (2016) Omkar U. Kawalekar et al. IMMUNITY
- Human Regulatory T Cells Mediate Transcriptional Modulation of Dendritic Cell Function
- (2016) Emily Mavin et al. JOURNAL OF IMMUNOLOGY
- Rheumatoid arthritis
- (2016) Josef S Smolen et al. LANCET
- Precision medicine for autoimmune disease
- (2016) Lucienne Chatenoud NATURE BIOTECHNOLOGY
- Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease
- (2016) C. T. Ellebrecht et al. SCIENCE
- A volcanic explosion of autoantibodies in systemic lupus erythematosus: A diversity of 180 different antibodies found in SLE patients
- (2015) Gal Yaniv et al. AUTOIMMUNITY REVIEWS
- De Novo–Induced Self-Antigen–Specific Foxp3+Regulatory T Cells Impair the Accumulation of Inflammatory Dendritic Cells in Draining Lymph Nodes
- (2015) Themis Alissafi et al. JOURNAL OF IMMUNOLOGY
- Type 1 diabetes immunotherapy using polyclonal regulatory T cells
- (2015) Jeffrey A. Bluestone et al. Science Translational Medicine
- Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors
- (2015) E. Wang et al. Cancer Immunology Research
- Systemic Sclerosis Patients Present Alterations in the Expression of Molecules Involved in B-Cell Regulation
- (2015) Lilian Soto et al. Frontiers in Immunology
- ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells
- (2014) S. Guedan et al. BLOOD
- Real world costs and cost-effectiveness of Rituximab for diffuse large B-cell lymphoma patients: a population-based analysis
- (2014) Sara Khor et al. BMC CANCER
- Suppression of Murine Colitis and its Associated Cancer by Carcinoembryonic Antigen-Specific Regulatory T Cells
- (2014) Dan Blat et al. MOLECULAR THERAPY
- Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis
- (2014) Loïc Guillevin et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for In Vivo Antitumor Activity
- (2014) M. Hudecek et al. Cancer Immunology Research
- Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning
- (2012) H. J. Pegram et al. BLOOD
- Local Delivery of lnterleukin-12 Using T Cells Targeting VEGF Receptor-2 Eradicates Multiple Vascularized Tumors in Mice
- (2012) D. Chinnasamy et al. CLINICAL CANCER RESEARCH
- Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin
- (2012) Ulrike Harre et al. JOURNAL OF CLINICAL INVESTIGATION
- CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery
- (2012) Moa Fransson et al. Journal of Neuroinflammation
- OX40 costimulation by a chimeric antigen receptor abrogates CD28 and IL-2 induced IL-10 secretion by redirected CD4+T cells
- (2012) Andreas A. Hombach et al. OncoImmunology
- Pro-survival signaling via CD27 costimulation drives effective CAR T-cell therapy
- (2012) De-Gang Song et al. OncoImmunology
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- IL-12 Release by Engineered T Cells Expressing Chimeric Antigen Receptors Can Effectively Muster an Antigen-Independent Macrophage Response on Tumor Cells That Have Shut Down Tumor Antigen Expression
- (2011) M. Chmielewski et al. CANCER RESEARCH
- SAR3419: An Anti-CD19-Maytansinoid Immunoconjugate for the Treatment of B-Cell Malignancies
- (2011) V. Blanc et al. CLINICAL CANCER RESEARCH
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- Systemic Lupus Erythematosus
- (2011) George C. Tsokos NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial
- (2010) P. P. Tak et al. ANNALS OF THE RHEUMATIC DISEASES
- Reduced-dose rituximab in rheumatoid arthritis: Efficacy depends on degree of B cell depletion
- (2010) Edward M. Vital et al. ARTHRITIS AND RHEUMATISM
- Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins
- (2010) Katleen Van Steendam et al. ARTHRITIS RESEARCH & THERAPY
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- 4-1BB and CD28 Signaling Plays a Synergistic Role in Redirecting Umbilical Cord Blood T Cells Against B-Cell Malignancies
- (2009) Syam Tammana et al. HUMAN GENE THERAPY
- Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo
- (2009) Xuyu Zhou et al. NATURE IMMUNOLOGY
- Redirection of Regulatory T Cells With Predetermined Specificity for the Treatment of Experimental Colitis in Mice
- (2008) Eran Elinav et al. GASTROENTEROLOGY
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation
- (2008) Y. Onishi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started